Hong Kong Renewable Energy Stock News

Hengan International Group recently granted 18.5 million existing shares, worth about HK$510 million, to 962 selected employees and directors under a long‑term incentive plan that will vest through January 2029 with service, conduct and clawback conditions. Because the awards are funded entirely by shares bought on the open market, the plan strengthens alignment between management and shareholders without adding financial assistance from the group itself. Next, we’ll consider how this...

361 Degrees International (SEHK:1361) just reported approximately 10% retail sales growth in both core and kids products for Q4 2025, alongside high double digit e commerce growth compared with the prior year period. See our latest analysis for 361 Degrees International. The latest trading update comes after a strong run for investors, with a year to date share price return of 9.67% and a 1 year total shareholder return of 55.03%. Over 5 years, the total shareholder return is more than 5x,...

MSCI recently upgraded Sino Land Company Limited’s ESG rating from ‘AA’ to the highest ‘AAA’ level, placing it among the top 5% of performers in its industry and recognizing its alignment with international environmental, social and governance standards. This move underscores how Sino Land is embedding ESG considerations into its long-term business strategy, using sustainability initiatives as a lever for value creation and innovation. We’ll now examine how Sino Land’s new MSCI ‘AAA’ ESG...

CGN Mining’s latest production update CGN Mining (SEHK:1164) has released unaudited natural uranium production figures for the fourth quarter and full year 2025, giving investors fresh data on volumes and operational output across its portfolio. See our latest analysis for CGN Mining. The fresh production figures land after a strong period for the stock, with a 24.66% 1 month share price return and a very large 5 year total shareholder return that suggests sustained investor interest rather...

BYD (SEHK:1211) is back in focus after reports that Ford is in talks to source BYD batteries for hybrid vehicles outside the U.S. This highlights how battery supply relationships can shape investor thinking. See our latest analysis for BYD. The Ford talks arrive after a choppy period for BYD's share price, with a 7 day share price return of 4.7% and a 30 day gain of 4.8%. The 90 day share price return shows a 4.0% decline, suggesting momentum has recently picked up from a softer patch, and...

If you are wondering whether Xiaomi's current share price reflects its true worth, you are not alone and this article is designed to help you frame that question clearly. Xiaomi's stock has seen mixed recent returns, with a 0.4% decline over 7 days, a 7.4% decline over 30 days and a 6.0% decline year to date, while still posting a 10.2% return over 1 year, a very large 3 year return and a 22.3% return over 5 years. Recent coverage has focused on how Xiaomi sits within the global smartphone...

As we enter 2026, Asian markets are experiencing a wave of investor optimism, with major indices reaching new highs despite ongoing geopolitical tensions. This backdrop presents an intriguing opportunity for investors exploring the realm of penny stocks—companies that may be small or relatively unknown but hold potential for significant growth. Though the term "penny stock" might sound outdated, these investments can still offer surprising value when backed by strong financial health. In this...

It's not a stretch to say that ETS Group Limited's ( HKG:8031 ) price-to-sales (or "P/S") ratio of 1x right now seems...

Key Insights The projected fair value for Simcere Pharmaceutical Group is HK$22.34 based on 2 Stage Free Cash Flow to...

The latest development at Alphamab Oncology (SEHK:9966) involves China’s regulator formally accepting its new drug application for KN035, in combination with Gemcitabine and Oxaliplatin, for first-line treatment of unresectable or metastatic biliary tract cancer. See our latest analysis for Alphamab Oncology. After the NMPA accepted the KN035 filing, Alphamab Oncology’s HK$10.28 share price sits alongside a 1-year total shareholder return of 216.31%, while the 90-day share price return of a...

Inspur Digital Enterprise Technology Limited ( HKG:596 ), is not the largest company out there, but it saw a...

Key Insights Significant insider control over Bloks Group implies vested interests in company growth The top 2...

Kwan Yong Holdings (HKG:9998) has had a great run on the share market with its stock up by a significant 17% over the...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Electronic industry in Hong Kong, you could be...

Key Insights Significant control over Scholar Education Group by individual investors implies that the general public...

With a price-to-earnings (or "P/E") ratio of 14.9x Jiangsu Innovative Ecological New Materials Limited ( HKG:2116 ) may...

Key Insights Using the 2 Stage Free Cash Flow to Equity, A & S Group (Holdings) fair value estimate is HK$0.11 A & S...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...

You may think that with a price-to-sales (or "P/S") ratio of 0.2x Golden Power Group Holdings Limited ( HKG:3919 ) is a...

When close to half the companies in the Entertainment industry in Hong Kong have price-to-sales ratios (or "P/S") below...

Key Insights ZhongAn Online P & C Insurance's significant retail investors ownership suggests that the key decisions...

The last three months have been tough on Unity Group Holdings International Limited ( HKG:1539 ) shareholders, who have...

Zhongsheng Group Holdings Limited ( HKG:881 ) shareholders should be happy to see the share price up 11% in the last...